Skip to main content
. 2017 Dec 26;18(1):1–11. doi: 10.1007/s40256-017-0260-1

Fig. 1.

Fig. 1

Effect of macitentan on morbidity or mortality as a first event in patients receiving background therapy [5]. The hazard ratio for macitentan vs. placebo was 0.62 (95% CL 0.43–0.89; log-rank p value 0.009). The Kaplan–Meier curves are displayed up to 36 months. The analysis (conducted on the all-randomized set) takes into account all available data